PACS Plunges After Nursing Co Delays 3Q Report, Addresses Hindenburg Report

Dow Jones
2024/11/06
 

By Rob Curran

 

Shares of nursing-home operator PACS Group slid after it delayed the release of its quarterly results, and said it was investigating allegations made in a critical report about the firm's practices from influential short-selling firm Hindenburg Research.

PACS, of Farmington, Utah, postponed the release of its earnings statement for the third quarter ended in September, pledging to disclose the update "as soon as practicable."

"PACS Group operates in a highly regulated industry where compliance is of the utmost importance," said Chief Executive Jason Murray, in a statement. "We believe recent third-party allegations are misleading. However, in line with our commitment to holding ourselves to a high standard--in how we serve our patients, operate our business, and engage with stakeholders--the company's audit committee, with assistance from external counsel, is conducting an investigation of the allegations."

The Hindenburg report accused PACS of "scamming taxpayers." In the report, Hindenburg claimed that interviews with former employees and competitors revealed systematic abuse of the Medicare system, with thousands of patients gaining "inappropriate" access to federally-funded insurance coverage.

In a preview of third-quarter results, PACS group said facilities occupancy was at 90.5%.

PACS said it acquired 56 facilities during the quarter, expanding into six new states so that it now has facilities in 15 states. The expansion added 2,889 skilled nursing beds and 1,334 assisted living and independent living units to its portfolio.

PACs estimated it had $600 million of cash and available liquidity on hand at the end of the quarter.

Shares of PACS Group slid 22% to $22.99 premarket.

 

Write to Rob Curran at rob.curran@dowjones.com

 

(END) Dow Jones Newswires

November 06, 2024 08:34 ET (13:34 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10